Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aflibercept plus chemotherapy in inoperable colorectal liver-only metastases
2014-000845-64Phase 2Terminated
- Sponsor
- Royal Marsden NHS Foundation Trust
- Start
- Jul 2015
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes, Engineered Antibody Formats → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised trial of aflibercept in colorectal cancer (CRC) (2 arms), sponsored by Royal Marsden NHS Foundation Trust. Started Jul 2015; status: terminated.
02
Drugs
aflibercept
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on 2014-000845-64.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000845-64.